Joseph Bertino, Pharm.D.
Independent ConsultantBertino Consulting
Joseph Bertino, PharmD, is an Associate Professor of Pharmacology at Columbia University College of Physicians and Surgeons in New York. Through Bertino Consulting, he consults to the pharmaceutical industry in areas of infectious diseases, drug metabolism, and clinical pharmacology. Dr. Bertino's research interests are in vaccines, antimicrobial pharmacokinetics and pharmacodynamics, pharmacogenetics, and pharmacogenomics. His publications include work in the area of aminoglycoside pharmacokinetics, pharmacodynamics and toxicity, drug-drug interactions, vaccine pharmacology, and application of pharmacogenetics to the drug development process. Dr. Bertino has also served on the Food and Drug Administration's Anti-infective and Antiviral Advisory Committees and remains as a special government employee. He is a recipient of the American College of Clinical Pharmacology Distinguished Investigator Award and the American College of Clinical Pharmacy Clinical Practice award. (This is me - Update Profile)
| 2007 - present | Independent Consultant Bertino Consulting |
|---|---|
| 2005 - present | Associate Professor of Pharmacology Columbia University College of Physicians and Surgeons |
| 2005 - 2007 | Scientific Director in Drug Development Center Ordway Research Institute Inc |
| 1997 - 2005 | Associate Professor of Clinical Pharmacology Columbia University |
| 1982 - 2005 | Section Chief of Clinical Pharmacology THE MARY IMOGENE BASSETT HOSPITAL, INC. |
GLG Study Groups with Joseph Bertino, Pharm.D.(?)
| Study Group Name | Members |
|---|---|
| Generic Drug Economic Experts | 635 |
| Generic Pharmaceuticals Regulation Experts: Healthcare Consultants | 27 |
| Cethromycin Experts | 23 |
GLG NewsSM Analyses by Joseph Bertino, Pharm.D.(?)
-Crestor sold 2.8 billion dollars in sales in the recent year, will this partnership result in long term exponential growth? -What are the implications for Crestor with generic simvastatin and with Lipitor going generic in the next few years? -Is a combination product going to bolster Crestor sales
-The new code will limit all gifts and meals to healthcare professionals, thus reducing pharmaceutical representative contact time. -Medical education programs will follow guidelines established by professional education groups -The guidelines do not go far enough for sales representative-healthcare...
A recent abstract for the 2007 Infectious Diseases Society of American (IDSA) meeting has generated some concern among financial analysts. This non-inferiority study on iclaprim versus linezolid for treatment of complicated skin and skin structure infections showed that “The 95% CI for treatment...
GLG InstituteSM Seminars with Joseph Bertino, Pharm.D.(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Joseph Bertino, Pharm.D.
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

